Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery
Clinical trial NCT02152761 · COMPLETED
Trial details
- NCT number
- NCT02152761
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-16
- Primary completion
- 2018-05-14
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.